| 标题 |
[求助补充材料]
 LBA23 Sacituzumab tirumotecan (sac-TMT) vs investigator's choice of chemotherapy (ICC) in previously treated locally advanced or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Results from the randomized, multi-center phase III OptiTROP-Breast02 study |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of Oncology 作者：Y. Fan; H. Li; H. Wang; S. Wang; H. Yu; et al 出版日期：2025-09-01 |
| 求助人 | |
| 下载 |
kongbaisaigao
Lv4 求助人 发起了本次求助
PDF的下载单位、IP信息已删除
(2025-6-4)
璐璐
v0id
林狗
极限001
xing_xing
aaaa
invisight
嘻嘻哈哈
学术文献互助
渡人舟
我能私信骂你吗
aajhajkahna
maxiaole
pluto
changping
OK
初景
CarryLJR
谢雷XIELei
整齐的孤菱
皖公网安备34019202002308
